Journal of Gastroenterology

Article	Citations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	187
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	100
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	91
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	82
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	67
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	65
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis	59
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	59
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	58
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	54
Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae	52
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts	51
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	46
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	45
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	40
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma	38
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	37
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	35
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	33
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver	33
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	32
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	32
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan	30
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	29
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	29

Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	29
Clinical practice guidelines for duodenal cancer 2021	29
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery	28
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis	28
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	27
Acknowledgements	26
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study	26
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan	26
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study	25
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey	25
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study	25
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation	24
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)	24
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan	23
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?	23
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	23
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan	23
Is it necessary for endoscopic surveillance for achalasia patients?	22
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021	22
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia	22
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study	21
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials	21
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study	20
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma	20
Targeting autophagy as a therapeutic strategy against pancreatic cancer	20
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19	19
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”	19
Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan	19
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime	19
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection	18
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)	18
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases	18
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer	18
Gastric cancer and genomics: review of literature	18
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway	18
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases	17
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?	17
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”	17
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments	16
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry	16
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic	16
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation	16
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma	16
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease	15
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)	15
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)	15
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 2023	15
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis	15
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society	15
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development	14

Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	14
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	14
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	14
AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions	14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy	14
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy	13
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy	13
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation	13
Renal manifestations in inflammatory bowel disease: a systematic review	13
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data	13
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	13
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation	13
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia	13
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance	13
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study	13
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study	13
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance	12
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer	12
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	12
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	12
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan	12
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	12
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	12
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY	12
Acknowledgements	12
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer	12
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	11
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	11
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway	11
The antiferroptotic effect of indigo on ulcerative colitis	11
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease	11
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis	11
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	11
Current status of type 1 (IgG4-related) autoimmune pancreatitis	11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co	11
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”	11
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors	11
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients	11
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”	10
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy	10
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"	10
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma	10
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer	10
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach	10
Acknowledgements	9
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc	9
Predictors of lymph node metastases, recurrence, and survival in patients with pedunculated-type T1 colorectal cancer	9
Correction to: Clinical guidelines for primary sclerosing cholangitis 2017	9
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma	9
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis	9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation	9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection	9
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease	9
Serum FGF19 combined with GGT and other biomarkers predicted native liver survival following Kasai portoenterostomy in early biliary atresia	9
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis	9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	9
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection	9
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus	9
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study	9
Cost–utility analysis of treatment strategies for chronic constipation in Japan	9
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis	8
Profile of plasma microRNAs as a potential biomarker of Wilson’s disease	8
Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials	8
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression	8
Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCRES	8
Correction: Current status and future perspective of linked color imaging for gastric cancer screening: a literature review	8
Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion	8
A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer	8
Correction: LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	8
The clinical outcome from early versus delayed minimally invasive intervention for infected pancreatic necrosis: a systematic review and meta-analysis	8
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease	8
Correction: Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	8
Kindlin-2–miR-1258–TCF4 feedback loop promotes hepatocellular carcinoma invasion and metastasis	8
Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502	8
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis	8
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter random	8
Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan	7
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR	7

Lipidomics and single-cell transcriptomics uncover aberrant lipid metabolism in metaplasia lesions during gastric carcinogenesis	7
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study	7
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization	7
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer	7
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma	7
An endoscopic real-time, in situ assessment of intestinal permeability in type 2 diabetes: links to microbiota and hyperglycemia	7
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases	7
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review	7
An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum	7
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe	7
Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression	7
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study	7
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia	7
Educational interventions to enhance support for balancing work and treatment in inflammatory bowel disease patients	7
Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis	7
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	7
Long-term risk of inflammatory bowel disease in patients with irritable bowel syndrome: the cross-sectional and longitudinal relationship	7
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells	7
Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospec	7
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia	7
The useful predictors of zinc deficiency for the management of chronic liver disease	6
Clinicopathological characteristics of colorectal serrated polyposis syndrome (SPS): results of a multicenter study by the SPS Study Group in Japan	6
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’	6
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients	6
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria	6
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression	6
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation	6
The clonal heterogeneity of colon cancer with liver metastases	6
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis	6
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease	6
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study	6
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan	6
Acknowledgements	6
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease	6
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	6
The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors	6
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases	6
Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients	5
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse	5
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes	5
The 2024 diagnostic criteria for primary sclerosing cholangitis	5
Factors associated with the development of bacterial pneumonia and the preventive potential of peroral endoscopic myotomy in patients with esophageal motility disorders: a case–control study	5
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicen	5
Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI	5
Current status of waitlist mortality and transplant probability for adult candidates with chronic end-stage liver disease for deceased donor liver transplantation under the Model for End-Stage Liver D	5
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort	5
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a	5
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices	5
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study	5
High-mobility group box 1: friend or foe in pancreatitis	5
Cox proportional hazards regression reveals more than a 100-fold difference in cancer risk by the length of Barrett’s esophagus in Japan	5
Clinical features and endoscopic polyp management of Peutz–Jeghers syndrome: the 2nd nationwide epidemiological survey in Japan	5
Possibility of determining high quantitative fecal occult blood on stool surface using hyperspectral imaging	5
Development of gastric mucosa-associated microbiota in autoimmune gastritis with neuroendocrine tumors	5
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan	5
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan	5
Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis	5
Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study	5
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program	5
Validation of Baveno VII criteria for recompensation in patients with decompensated cirrhosis treated by laparoscopic splenectomy and azygoportal disconnection	5
Thiopurines exert harmful effects on spermatogenesis in Nudt15R138C knock-in mice	5
Reply to “Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis”	4
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD	4
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2	4
Clinical impact of epithelial types on postoperative outcomes for intraductal papillary mucinous neoplasms: a multicenter retrospective study	4
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension	4
Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis	4
Identification of anti-Helicobacter pylori antibody signatures in gastric intestinal metaplasia	4
Comparing the predictive ability of portoatrial and portocaval gradient after transjugular intrahepatic portosystemic shunt creation for variceal rebleeding	4
A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma	4
Asia Pacific Gastroesophageal Cancer Congress (APGCC) 2024 consensus statement on stage 2 and 3 locally advanced gastric and Siewert 3 junctional adenocarcinoma	4
Group 1 innate lymphoid cells and inflammatory macrophages exacerbate fibrosis in creeping fat through IFN-γ secretion	4
Postinfectious onset in functional dyspepsia is a risk factor for weight loss	4
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting	4
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments	4
Correction: The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection	4
Paired liver–spleen high-frequency ultrasound deep learning network for full-stage liver fibrosis classification and clinical benefit compared with 2D-SWE in chronic hepatitis B cohort: a prospective	4
Management of colorectal high-grade dysplasia or cancer resected by cold snare polypectomy: a multicenter exploratory study	4
Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis	4
Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a mul	4
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank	4
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study	4
Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptoms	4
Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?	4
Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–2017	4
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis	4
Predictive factors for primary nonresponse to biologics in ulcerative colitis: a prospective multicenter study	3
Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation	3
Impact of preceding treatment for head and neck squamous cell carcinoma on synchronous superficial esophageal squamous cell carcinoma	3
Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity	3
Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis	3
Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma	3
Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy	3
Ferroptosis: biology and role in liver disease	3
Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database	3